BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17891599)

  • 1. Relationship between estrogen receptor-alpha polymorphism and serum levels of vascular cell adhesion molecule-1, intercellular adhesion molecule-1, C-reactive protein and homocysteine in postmenopausal women.
    Jakimiuk AJ; Bogusiewicz M; Skorupski P; Adamiak A; Miotła P; Haczyński J; Rechberger T
    Gynecol Endocrinol; 2007 Oct; 23(10):584-9. PubMed ID: 17891599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor alpha gene polymorphisms are associated with changes in bone remodeling markers and treatment response to estrogen.
    Rapuri PB; Gallagher JC; Knezetic JA; Haynatzka V
    Maturitas; 2006 Mar; 53(4):371-9. PubMed ID: 16139450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consumption of isoflavone-rich soy protein does not alter homocysteine or markers of inflammation in postmenopausal women.
    Greany KA; Nettleton JA; Wangen KE; Thomas W; Kurzer MS
    Eur J Clin Nutr; 2008 Dec; 62(12):1419-25. PubMed ID: 17805230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
    Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
    Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor (ER) gene polymorphism may predict the bone mineral density response to raloxifene in postmenopausal women on chronic hemodialysis.
    Heilberg IP; Hernandez E; Alonzo E; Valera R; Ferreira LG; Gomes SA; Bellorin-Font E; Weisinger JR
    Ren Fail; 2005; 27(2):155-61. PubMed ID: 15807179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The estrogen receptor alpha gene and breast cancer risk (The Netherlands).
    Onland-Moret NC; van Gils CH; Roest M; Grobbee DE; Peeters PH
    Cancer Causes Control; 2005 Dec; 16(10):1195-202. PubMed ID: 16215870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor gene polymorphisms in a group of postmenopausal Turkish women: association with bone mineral density.
    Yavuz DG; Yoldemir T; Ozaltun K; Erenus M
    Climacteric; 2012 Aug; 15(4):368-73. PubMed ID: 22141363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of estrogen receptor-alpha polymorphism with symptoms and other characteristics in post-menopausal women.
    Malacara JM; Pérez-Luque EL; Martínez-Garza S; Sánchez-Marín FJ
    Maturitas; 2004 Oct; 49(2):163-9. PubMed ID: 15474761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MTHFR 677 C/T polymorphism influences plasma levels of adhesion molecules and nitric oxide.
    Juo SH; Liao YC; Kuo CL; Wang Y; Huang CS; Chiang HC; Liu CS
    Thromb Res; 2008; 121(4):549-54. PubMed ID: 17707074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy.
    de Maat MP; Madsen JS; Langdahl B; Bladbjerg EM; Tofteng CL; Abrahamsen B; Rejnmark L; Brixen K; Christensen K; Jespersen J; Kristensen SR
    Thromb Haemost; 2007 Feb; 97(2):234-9. PubMed ID: 17264952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined effect of interleukin-6 and estrogen receptor gene polymorphisms on bone mass in postmenopausal women].
    Liu JM; Zhu HM; Zhu XY; Dai M; Jiang L; Xu MY; Chen JL
    Zhonghua Fu Chan Ke Za Zhi; 2003 Jan; 38(1):24-7. PubMed ID: 12757654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response.
    Silvestri A; Gebara O; Vitale C; Wajngarten M; Leonardo F; Ramires JA; Fini M; Mercuro G; Rosano GM
    Circulation; 2003 Jul; 107(25):3165-9. PubMed ID: 12796135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid profile and inflammatory markers associated with estrogen receptor alpha PvuII and XbaI gene polymorphisms.
    Boroumand M; Ghaedi M; Mohammadtaghvaei N; Pourgholi L; Anvari MS; Davoodi G; Amirzadegan A; Saadat S; Sheikhfathollahi M; Goodarzynejad H
    Transl Res; 2009 Jun; 153(6):288-95. PubMed ID: 19446283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women.
    Kim H; Chun S; Ku SY; Suh CS; Choi YM; Kim JG
    Menopause; 2009; 16(5):1014-20. PubMed ID: 19369902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adhesion molecules (VCAM-1 and ICAM-1) and C-reactive protein in women with history of preeclampsia.
    Portelinha A; Belo L; Tejera E; Rebelo I
    Acta Obstet Gynecol Scand; 2008; 87(9):969-71. PubMed ID: 18720045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between oestrogen receptor alpha gene polymorphism and mortality in female end-stage renal disease patients.
    Kato S; Lindholm B; Axelsson J; Qureshi RA; Barany P; Heimbürger O; Gustafsson JA; Stenvinkel P; Nordfors L
    Nephrol Dial Transplant; 2007 Sep; 22(9):2571-7. PubMed ID: 17452407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor alpha gene polymorphism associated with type 2 diabetes mellitus and the serum lipid concentration in Chinese women in Guangzhou.
    Huang Q; Wang TH; Lu WS; Mu PW; Yang YF; Liang WW; Li CX; Lin GP
    Chin Med J (Engl); 2006 Nov; 119(21):1794-801. PubMed ID: 17097034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No increase in C-reactive protein levels during intranasal compared to oral hormone therapy in healthy post-menopausal women.
    Hemelaar M; Kenemans P; Schalkwijk CG; Braat DD; van der Mooren MJ
    Hum Reprod; 2006 Jun; 21(6):1635-42. PubMed ID: 16501036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the XbaI polymorphism of estrogen receptor alpha on postmenopausal gray matter.
    Boccardi M; Scassellati C; Ghidoni R; Testa C; Benussi L; Bonetti M; Bocchio-Chiavetto L; Gennarelli M; Binetti G; Frisoni GB
    Neurosci Lett; 2008 Apr; 434(3):304-9. PubMed ID: 18342444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone addition to estrogen therapy - effects on inflammatory markers for cardiovascular disease.
    Kocoska-Maras L; Hirschberg AL; Byström B; Schoultz BV; Rådestad AF
    Gynecol Endocrinol; 2009 Dec; 25(12):823-7. PubMed ID: 19906002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.